Abstracts

Online abstract submission is now closed. All abstract submitters have been informed.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Abstract submission is now open till March 1, 2017!


General guidelines
Abstracts should contain the following four components:

  • Background
    A concise statement of the issue under investigation or a hypothesis;
  • Material & Methods
    The experimental methods used (including the statistical analyses employed);
  • Results
    Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
  • Conclusions
    A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically until 1 March 2017 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Click here for an overview of the categories.

Young Professionals
We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

Free registrations/discounts are offered to:
- young professionals in training
- young professionals who have obtained an MD/PhD degree in the last five years

In order to receive a special registration code the young professional needs to ask a supervisor to complete the application form and send it to: Kun-Chieh.Wu@vironet.com prior to 1 March 2017.

IMPORTANT: free registration is offered to the presenting author of the abstract only.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the status of the abstract. Please notify the Conference Secretariat if you have not received notification by the second week of Aprtil. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

General Guidelines

​Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Procedure

Authors can submit their abstracts electronically using the button on the right “Abstract or case report submission”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission
Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation.

Abstracts can be submitted under the following categories:
• The life cycle of an HIV infected patient
• Current treatment paradigms and strategies in European HIV clinic
• Short and long term toxicities in renal, bone and cardiovascular systems
• Comprehensive care of aging HIV infected individuals and their co-morbidities

Abstracts

Please read the guidelines carefully before submitting your abstract.
Deadline for abstract submission is March 2

General Guidelines
Abstracts should contain the following four components:
Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable, including statistical analyses;
Conclusions: a summary of findings that are supported by your results;  concluding statements such as "the results will be discussed" are not acceptable.

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically using the button on the right "Submit here". (button will be placed soon) You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Abstracts can be submitted for the following topics:

  • Antiretroviral treatment and HIV care; Co-morbidities
  • Basic science
  • Epidemiology
  • HIV prevention
  • Stigma and discrimination
  • Community/civil society engagement
  • Health systems and HIV
  • Laboratory monitoring/diagnostics
  • Operational research / implementation science
  • Paediatrics and PMTCT 
  • Economics, financing, policy, regulatory and ethical issues
  • Key Populations: prevention and treatment challenges
  • Women and HIV

Young Investigators/Postdoc/MD
We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format
It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will

Abstracts

Abstract submission is open!

IMPORTANT: Abstracts that have been accepted for CROI can also be submitted to the HIV & Women workshop. If your abstract is accepted for presentation at both meetings, please note that results of presentations at the HIV & Women workshop should not be released outside the workshop in press releases or announced in a publication or other public forum prior to their presentation at CROI.

General guidelines

Abstracts should contain the following four components:
Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.
The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically using the button on the right "Abstract Submission" until 2 December 2016. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract.
To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract.
The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission

Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Abstracts will be accepted either for oral or poster presentation;

Abstracts can be submitted under the following categories:
- Epidemiology of HIV in women and girls
- HIV prevention in women
- Diagnosis and treatment of HIV Infection
- Contraception, pregnancy, breastfeeding, and PMTCT
- Comorbidities in HIV infected women
- Special Populations: Sexworkers, Transgenders
- Women Living with HIV

Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract.
IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; 
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

ABSTRACT SUBMISSION is closed
All abstracts are now under review by the Organizing and Scientific Committee members

General guidelines
Abstracts should contain the following four components:

Background
A concise statement of the issue under investigation or a hypothesis;
Material & Methods
the experimental methods used (including the statistical analyses employed);
Results
Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions
a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically until 1 February 2016 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Click here for an overview of the categories.

 

Young Professionals
We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

Free registrations/discounts are offered to:
- young professionals in training
- young professionals who have obtained an MD/PhD degree in the last five years

In order to receive a special registration code the young professional needs to ask a supervisor to complete the application form and send it to: Kun-Chieh.Wu@vironet.com prior to 1 February 2016.

IMPORTANT: free registration is offered to the presenting author of the abstract only.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the status of the abstract. Please notify the Conference Secretariat if you have not received notification by the second week of March. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Late--breaker deadline: 29 July 2016

 General guidelines

Abstracts should contain the following four components:

  • Background: a concise statement of the issue under investigation or a hypothesis;
  • Materials & Methods: the experimental methods used (including the statistical analyses employed);
  • Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
  • Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically using the button on the right “Abstract Submission”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission

Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation.

Abstracts can be submitted under the following categories:

  • Liver cancer
  • Liver transplantation
  • Liver Steatosis
  • Hepatitis Drug Resistance
  • New anti-HCV agents
  • Treatment issues --- Hepatitis-HIV coinfection
  • Drug Interactions --- Hepatitis ARTs
  • Monitoring and diagnostic tools
Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:

  • be 30 years of age or younger; or,
  • be a Master/PhD student; or,
  • have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Abstract Submission is closed.
Abstracts are under review by the Organizing and Scientific Committee.

General guidelines
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially.
Submitters of acccepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically until 1 May using “Submit Abstract Here” tab (available as soon as registration opens.) This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format. (see for further information

Dual abstract submission IAS
As in previous years, the workshop is preceding and endorsed by the IAS Conference (IAS 2015). Dual abstract submission to IAS 2015 is possible! Dual submission will provide you with the opportunity to discuss your data in-depth with your international colleagues at this closed HIV Pediatrics workshop and will allow major exposure during IAS 2015.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics
We encourage you to submit your abstracts focussed on children and/or adolescents for the following Topics:

- Prevention of mother to child HIV transmission (PMTCT) (including issues for HIV-uninfected, exposed children)
- Antiretroviral treatment of pediatric HIV infection
- Complications of HIV and its treatment in children
- Co-infections in HIV-infected children
- Comprehensive pediatric HIV care
- HIV infection and adolescents (perinatally and behaviorally infected)
- Implementation science research on PMTCT and pediatric treatment programs

Young Investigators/Postdoc/MD
We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: the free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

An Award will be granted to the young investigator with the best abstract. The Scientific Committee and Organizing Committee will judge all submitted abstracts. The award winner will be announced at the workshop.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors in May. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.
Please notify the Conference Secretariat if you have not received notification by the end of May.
If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.
Abstract Submitter’s Registration Guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Conference Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal "Reviews in Antiviral Therapy & Infectious Diseases". Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

  • Online abstract submission is closed. If you still want to submit your data, send your abstract as Word doc to wilco.keulen@vironet.com.
  • Workshop embargo policy: Research abstracts may be submitted to both the International Workshop on HIV Transmission 2016 and to HIVR4P 2016. In view of the partnership with HIVR4P 2016, all presentations given at the 11th International Workshop on HIV Transmissions that are also given at HIVR4P 2016 are embargoed until after the time of their presentation at HIVR4P 2016. All regular delegates, presenters and media are asked to respect this policy before and during the Workshop and HIVR4P 2016. Please click HERE to view the details.
  • Conference participation grant: we are pleased to offer a number of participation grants to young professionals (investigators) with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

General guidelines
Abstracts should contain the following four components:

Background
A concise statement of the issue under investigation or a hypothesis;
Material & Methods
the experimental methods used (including the statistical analyses employed);
Results
Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions
a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically until 26 August 2016 by using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics:
- Behavioral risk factors affecting HIV Transmission
- Biology of HIV Transmission
- Biomedical Approaches for HIV prevention of transmission
- Epidemiology of HIV Transmission
- Modeling of HIV Transmission
- Mother to Child Transmission
- Transmission by Intravenous Drug Users
- Transmission of HIV Drug Resistance
- Virology of HIV Transmission

Young Professionals 
We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

Free registrations/discounts are offered to:
- young professionals in training
- young professionals who have obtained an MD/PhD degree in the last five years

In order to receive a special registration code the young professional needs to ask a supervisor to complete the application form and send it to: kun-chieh@vironet.com prior to 1 October 2016.

IMPORTANT: free registration is offered to the presenting author of the abstract only.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by the second week of October. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Abstract submission is closed. 

We encourage you to submit abstracts on your research in this field.

Topics for abstract submission:
- Pathogenesis
- Microbicides/Vaccines
- Comorbidities
- Transmission & Prevention
- Treatment & Cure
- Technologies & Methodologies

General guidelines
Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Material & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Unfortunately, the abstract submission deadline has already passed and no more abstracts can be submitted.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by the end of February.

If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

ABSTRACT SUBMISSION WILL OPEN SHORTLY
DEADLINE FOR ABSTRACT SUBMISSION: 14 APRIL 2017

IMPORTANT: Abstracts including data previously presented at other scientific conferences will be considered for acceptance, but data already published will not be considered.

General guidelines

Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Material & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically until 14 April 2017 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics:
will be posted shortly.

Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger;
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Notification of abstract acceptance and presentation format

Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting author in week 19 latest. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by mid May.

If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

General guidelines

Abstracts should contain the following four components:

  • Background: a concise statement of the issue under investigation or a hypothesis;
  • Materials & Methods: the experimental methods used (including the statistical analyses employed);
  • Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
  • Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically using the button on the right “Abstract Submission” until 31 March 2017. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission

Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation.

Abstracts can be submitted under the following categories:

  • Mechanism of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
  • Resistance to Antiviral Drugs (Hepatitis B, Hepatitis C and HIV)
  • Spread of Drug Resistance
  • Clinical Implications of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
  • Novel Diagnostic Technologies & Approaches
  • Treatment Strategies for HIV/ Hepatitis infected Patients
  • Therapeutic Challenges in Resource-limited settings
  • Viral Evolution & Genetic Diversity
  • Clinical case
Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should: 

  • be 30 years of age or younger;
  • be a Master/PhD student; or, 
  • have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

ONLINE ABSTRACT SUBMISSION IS CLOSED!

*HIV transmission abstracts may be co-submitted to the HIV Research for Prevention Meeting (HIV R4P), which will take place 28-31 October 2014, Cape Town, South Africa, just after the 9th International Workshop on HIV Transmission - Principles of Intervention. For more on this meeting, please visit: http://hivr4p.org/

General guidelines
Abstracts should contain the following four components:

Background
A concise statement of the issue under investigation or a hypothesis;
Material & Methods
the experimental methods used (including the statistical analyses employed);
Results
Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions
a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically until 29 August 2014  using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission will be announced soon!

Topics:
- Behavioral risk factors affecting HIV Transmission 
- Biology of HIV Transmission
- Biomedical Approaches for HIV prevention of transmission
- Epidemiology of HIV Transmission
- Modeling of HIV Transmission
- Mother to Child Transmission
- Transmission by Intravenous Drug Users
- Transmission of HIV Drug Resistance 
- Virology of HIV Transmission

Young Investigators/Postdoc/MD
We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract.

The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs  to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

IMPORTANT: free registration is offered to the presenting author of the abstract only.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by the second week of September. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Online abstracts submission is not yet open.
Abstract submission deadline is 10 March 2017.


General guidelines
Abstracts should contain the following four components:
Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.
The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically using the button on the right “Submit here”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract.
To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract.
The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission
Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Abstracts will be accepted either for oral or poster presentation;

Abstracts can be submitted under the following categories:
- Drug Drug Interactions
- Novel Drugs and Formulations
- Pharmacokinetics for Pediatrics, Pregnancy and other Special Populations
- PK-PD of Drug Efficacy and Toxicity
- Pharmacogenetics
- Therapeutic Drug Monitoring
- PK/PD modeling
- Other viruses

Young Investigators/Postdoc/MD
We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract.
IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format
It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Abstract submission will open on 15 December and will close on 28 April.

General guidelines
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially.
Submitters of acccepted abstracts agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically using “Submit Abstract Here” tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format. (see for further information her below)

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics
We encourage you to submit your abstracts focussed on children and/or adolescents for the following Topics:

- Prevention of mother to child HIV transmission (PMTCT) (including issues for HIV-uninfected, exposed children)
- Antiretroviral treatment of pediatric HIV infection
- Complications of HIV and its treatment in children
- Co-infections in HIV-infected children
- Comprehensive pediatric HIV care
- HIV infection and adolescents (perinatally and behaviorally infected)
- Implementation science research on PMTCT and pediatric treatment programs

Young Professionals

We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.

In order to receive a special registration code the young professional needs to ask a supervisor to complete the application form and send it to Jo-Els van der Woude (jo-els@vironet.com) prior to 10 June 2017.

Free registrations/discounts are granted to:
- young professionals in training
- young professionals who have obtained an MD/PhD degree in the last five years

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

An Award will be granted to the young investigator with the best abstract. The Scientific Committee and Organizing Committee will judge all submitted abstracts. The award winner will be announced during the second workshop day.

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors before 1 June.  It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.
Please notify the Conference Secretariat if you have not received notification by June 1.  If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.
Abstract Submitter’s Registration Guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Conference Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal "Reviews in Antiviral Therapy & Infectious Diseases". Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

General guidelines

Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed); Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically using the button on the right “Abstract Submission”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics for abstract submission

Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation.

Abstracts can be submitted under the following categories:

  • Liver cancer
  • Resistance ---  Hepatitis B
  • Resistance --- Hepatitis C
  • New anti-HCV agents
  • Liver transplantation
  • Delta Hepatitis
  • Treatment issues --- HBV-HIV coinfection
  • Treatment issues --- HCV-HIV coinfection
  • Liver toxicity
  • Drug Interactions --- Hepatitis ARTs
  • Non invasive assessment of liver fibrosis
  • Liver Steatosis
Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:

  • be 30 years of age or younger; or,
  • be a Master/PhD student; or,
  • have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.

Notification of abstract acceptance and presentation format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

EXTENDED ABSTRACT SUBMISSION DEADLINE: 29 July

IMPORTANT: Abstracts including data previously presented at other scientific conferences will be considered for acceptance, but data already published will not be considered. Pending abstract for other large meetings, such as CROI, are allowed.

General guidelines

Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Material & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically until 29 July 2016 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics:
- Neurology
- Pharmacology
- Immunology
- Metabolic/ cardiovascular complications
- Effect of aging on organ systems (renal, musculoskeletal, hepatic and endocrine)
- Malignancy
- Geriatrics and Clinical care

Young Investigators/Postdoc/MD

  We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; 
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Notification of abstract acceptance and presentation format

Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to submitting author in week 38. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by the end of September.

If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

Abstracts

Abstract submission is closed.
The submitted abstracts are now under review.

 

IMPORTANT: Abstracts including data previously presented at other scientific conferences will be considered for acceptance, but data already published will not be considered. Pending abstract for other large meetings, such as CROI, are allowed.

General guidelines

Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Material & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission

Authors can submit their abstracts electronically until 29 February 2016 using the button on the right hand tab. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

Topics:
- Treatment strategies in patients with Advanced Liver Disease
- Treatment strategies in HCV patients prior to Liver Transplantation
- Treatment strategies in liver transplant-recipients

Young Investigators/Postdoc/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.

Notification of abstract acceptance and presentation format

Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed (or faxed if you did not supply an e-mail address) to submitting author before the end of February. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract's status. Please notify the Conference Secretariat if you have not received notification by the end of September.

If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.